Company / SG&A per Share
Beam Therapeutics Inc. SG&A per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$1.12
FY2025
5-year range
$0.84 / $1.43
FY2021-FY2025
Trend
-16.1%
vs FY2024
Sector context
#113 of 210
Health Care
What the data says
At $1.12, Beam Therapeutics Inc.'s sg&a per share ranks #98 of 210 in the Health Care sector. Improved from $1.43 to $1.12 over the past 2 years.
Based on SEC 10-K filings.
1.12 in FY2025 with a 5-year CAGR of -16.8%.
Improved from $1.43 to $1.12 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- -3.2%
- 5-Year CAGR
- -16.8%
- 10-Year CAGR
- -
Sector benchmark
#98 of 210 in Health CareTop 46% of 210This company $1.12 Sector average $40.75
▼
-97.3% below sector average
Key checks
Key Insights
- In FY2025, sg&a per share decreased 16.1% year-over-year.
- Ranks #113 out of 210 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2019.
- Lowest sg&a per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 1.06 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.12 | -16.1% |
| FY2024 | $1.33 | -6.8% |
| FY2023 | $1.43 | +16.2% |
| FY2022 | $1.23 | +47.2% |
| FY2021 | $0.84 | -70.2% |
| FY2020 | $2.81 | -11.6% |
| FY2019 | $3.17 | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026